Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes.

Cousminer DL, Ahlqvist E, Mishra R, Andersen MK, Chesi A, Hawa MI, Davis A, Hodge KM, Bradfield JP, Zhou K, Guy VC, Åkerlund M, Wod M, Fritsche LG, Vestergaard H, Snyder J, Højlund K, Linneberg A, Käräjämäki A, Brandslund I, Kim CE, Witte D, Sørgjerd EP, Brillon DJ, Pedersen O, Beck-Nielsen H, Grarup N, Pratley RE, Rickels MR, Vella A, Ovalle F, Melander O, Harris RI, Varvel S, Grill VER; Bone Mineral Density in Childhood Study, Hakonarson H, Froguel P, Lonsdale JT, Mauricio D, Schloot NC, Khunti K, Greenbaum CJ, Åsvold BO, Yderstræde KB, Pearson ER, Schwartz S, Voight BF, Hansen T, Tuomi T, Boehm BO, Groop L, Leslie RD, Grant SFA.

Diabetes Care. 2018 Nov;41(11):2396-2403. doi: 10.2337/dc18-1032. Epub 2018 Sep 25.

PMID:
30254083
2.

Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial.

Punthakee Z, Miller ME, Simmons DL, Riddle MC, Ismail-Beigi F, Brillon DJ, Bergenstal RM, Savage PJ, Hramiak I, Largay JF, Sood A, Gerstein HC; ACCORD Group of Investigators.

Diabetologia. 2014 Oct;57(10):2030-7. doi: 10.1007/s00125-014-3318-5. Epub 2014 Jul 2.

3.

Comparative effectiveness of oral diabetes drug combinations in reducing glycosylated hemoglobin.

Flory JH, Small DS, Cassano PA, Brillon DJ, Mushlin AI, Hennessy S.

J Comp Eff Res. 2014 Jan;3(1):29-39. doi: 10.2217/cer.13.87.

4.

Diabetes control among Hispanics in the action to control cardiovascular risk in diabetes trial.

Getaneh A, Light LS, Brillon DJ, Calles Escandón J, Felicetta J, Evans GW, Lopez-Jimenez CR, Cuddihy R, Bigger JT.

J Gen Intern Med. 2012 Nov;27(11):1499-505. doi: 10.1007/s11606-012-2131-4. Epub 2012 Jun 29.

5.

Hemoglobin A(₁c) criterion for diabetes diagnosis among Hispanic and non-Hispanic populations.

Getaneh A, Andres R, Brillon DJ, Findley SE.

Endocr Pract. 2011 Mar-Apr;17(2):210-7. doi: 10.4158/EP10119.OR.

PMID:
20841311
6.

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.

Riddle MC, Ambrosius WT, Brillon DJ, Buse JB, Byington RP, Cohen RM, Goff DC Jr, Malozowski S, Margolis KL, Probstfield JL, Schnall A, Seaquist ER; Action to Control Cardiovascular Risk in Diabetes Investigators.

Diabetes Care. 2010 May;33(5):983-90. doi: 10.2337/dc09-1278.

7.

Metabolic and hormonal effects of oral DHEA in premenopausal women with HIV infection: a randomized, prospective, placebo-controlled pilot study.

Poretsky L, Song L, Brillon DJ, Ferrando S, Chiu J, McElhiney M, Ferenczi A, Sison C, Haller I, Rabkin J.

Horm Metab Res. 2009 Mar;41(3):244-9. doi: 10.1055/s-0028-1087175. Epub 2008 Sep 22.

8.

Reproducibility of a glycemic response to mixed meals in type 2 diabetes mellitus.

Brillon DJ, Sison CP, Salbe AD, Poretsky L.

Horm Metab Res. 2006 Aug;38(8):536-42.

PMID:
16941281
9.

Glucose testing and insufficient follow-up of abnormal results: a cohort study.

Kern LM, Callahan MA, Brillon DJ, Vargas M, Mushlin AI.

BMC Health Serv Res. 2006 Jul 12;6:87.

10.

Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial.

Poretsky L, Brillon DJ, Ferrando S, Chiu J, McElhiney M, Ferenczi A, Sison MC, Haller I, Rabkin J.

Metabolism. 2006 Jul;55(7):858-70.

PMID:
16784956
11.

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.

Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, O'Leary DH, Genuth S; Diabetes Control and Complications Trial; Epidemiology of Diabetes Interventions and Complications Research Group.

N Engl J Med. 2003 Jun 5;348(23):2294-303.

12.

Splanchnic bed utilization of enteral alpha-ketoisocaproate in humans.

Matthews DE, Harkin R, Battezzati A, Brillon DJ.

Metabolism. 1999 Dec;48(12):1555-63.

PMID:
10599988
13.

Splanchnic utilization of enteral alanine in humans.

Battezzati A, Haisch M, Brillon DJ, Matthews DE.

Metabolism. 1999 Jul;48(7):915-21.

PMID:
10421236
14.

Epinephrine produces a prolonged elevation in metabolic rate in humans.

Ratheiser KM, Brillon DJ, Campbell RG, Matthews DE.

Am J Clin Nutr. 1998 Nov;68(5):1046-52.

PMID:
9808221
15.

Oxidation of glutamic acid by the splanchnic bed in humans.

Battezzati A, Brillon DJ, Matthews DE.

Am J Physiol. 1995 Aug;269(2 Pt 1):E269-76.

PMID:
7653544
16.

Effect of cortisol on energy expenditure and amino acid metabolism in humans.

Brillon DJ, Zheng B, Campbell RG, Matthews DE.

Am J Physiol. 1995 Mar;268(3 Pt 1):E501-13.

PMID:
7900796
17.

Mechanism of defective insulin-receptor kinase activity in NIDDM. Evidence for two receptor populations.

Brillon DJ, Freidenberg GR, Henry RR, Olefsky JM.

Diabetes. 1989 Mar;38(3):397-403.

PMID:
2465197
18.

Functional and structural differences in human and rat-derived insulin receptors: characterization of the beta-subunit kinase activity.

Brillon DJ, Henry RR, Klein HH, Olefsky JM, Freidenberg GR.

Endocrinology. 1988 Oct;123(4):1837-47.

PMID:
2843349

Supplemental Content

Loading ...
Support Center